Insider Transactions in Q1 2021 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2021
|
Jon M Foster EVP and COO |
SELL
Open market or private sale
|
Direct |
6,171
-100.0%
|
$1,086,096
$176.44 P/Share
|
|
Feb 08
2021
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
4,308
-14.39%
|
$766,824
$178.94 P/Share
|
|
Feb 08
2021
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+21.09%
|
$544,000
$68.96 P/Share
|
|
Feb 05
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
13,718
-32.68%
|
$2,414,368
$176.22 P/Share
|
|
Feb 05
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Open market or private sale
|
Direct |
10,000
-8.64%
|
$1,790,000
$179.93 P/Share
|
|
Feb 05
2021
|
Robert A Waterman SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
62,936
-15.46%
|
$11,139,672
$177.38 P/Share
|
|
Feb 04
2021
|
Jon M Foster EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,829
-48.58%
|
$1,043,391
$179.3 P/Share
|
|
Feb 04
2021
|
Jon M Foster EVP and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$564,000
$47.97 P/Share
|
|
Feb 04
2021
|
Charles J Hall Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,507
-4.85%
|
$1,880,753
$179.3 P/Share
|
|
Feb 04
2021
|
Charles J Hall Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
16,028
+3.63%
|
$1,458,548
$91.56 P/Share
|
|
Feb 04
2021
|
J William Morrow SVP - Finance and Treasurer |
BUY
Bona fide gift
|
Indirect |
227
+10.23%
|
-
|
|
Feb 04
2021
|
J William Morrow SVP - Finance and Treasurer |
SELL
Bona fide gift
|
Direct |
227
-17.72%
|
-
|
|
Feb 04
2021
|
P. Martin Paslick SVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,025
-47.74%
|
$899,475
$179.3 P/Share
|
|
Feb 04
2021
|
P. Martin Paslick SVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,525
+50.0%
|
$494,675
$47.97 P/Share
|
|
Feb 04
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,721
-41.09%
|
$6,752,059
$179.3 P/Share
|
|
Feb 04
2021
|
Jonathan B Perlin Pres-Clinical Operations & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
69,375
+43.04%
|
$3,260,625
$47.97 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
6,733
-31.86%
|
$1,205,207
$179.3 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,150
+30.22%
|
$924,150
$101.16 P/Share
|
|
Feb 04
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
3,516
-11.81%
|
$618,816
$176.0 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
653
-13.99%
|
$116,887
$179.3 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+23.07%
|
$65,800
$47.97 P/Share
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Bona fide gift
|
Direct |
415
-11.26%
|
-
|
|
Feb 04
2021
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
280
-7.06%
|
$49,560
$177.11 P/Share
|
|
Feb 04
2021
|
Wayne Joseph Riley Director |
SELL
Open market or private sale
|
Direct |
1,650
-11.69%
|
$288,750
$175.0 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
7,574
-15.29%
|
$1,295,154
$171.17 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,772
-32.42%
|
$4,112,556
$173.12 P/Share
|
|
Feb 03
2021
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,490
+22.75%
|
$2,811,750
$75.77 P/Share
|
|
Feb 03
2021
|
A Bruce Moore Jr Group President - Service Line |
SELL
Payment of exercise price or tax liability
|
Direct |
22,848
-16.48%
|
$3,952,704
$173.12 P/Share
|
|
Feb 03
2021
|
A Bruce Moore Jr Group President - Service Line |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.51%
|
$1,100,000
$22.95 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
1,550
-9.09%
|
$263,500
$170.94 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Payment of exercise price or tax liability
|
Direct |
8,375
-32.95%
|
$1,448,875
$173.12 P/Share
|
|
Feb 03
2021
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
BUY
Exercise of conversion of derivative security
|
Direct |
13,758
+17.85%
|
$1,045,608
$76.22 P/Share
|
|
Feb 03
2021
|
Robert A Waterman SVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
140,711
-25.69%
|
$24,343,003
$173.12 P/Share
|
|
Feb 03
2021
|
Robert A Waterman SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
277,500
+16.66%
|
$9,990,000
$36.03 P/Share
|
|
Feb 03
2021
|
Wayne Joseph Riley Director |
SELL
Open market or private sale
|
Direct |
1,650
-10.46%
|
$273,900
$166.19 P/Share
|